Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy

Overview of attention for article published in Frontiers in immunology, May 2023

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 33,599 followers.

RT @FrontImmunol: New Research: Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocy…

08 May 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocy…

08 May 2023

Reply Repost Favourite

New Research: Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy: Background Ofatumumab, a fully humanized anti-CD20 monoclonal antibody, has shown promising efficacy in limited… #immunology

08 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.